Platelet-Rich Blood Derivatives for Stem Cell-Based Tissue Engineering and Regeneration
Current Stem Cell Reports · 2016-03 · 2 (1) · 33-42
DOI: 10.1007/s40778-016-0034-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Stem Cell Reports, online erschienen am 13.02.2016. Verfasst von Elham Masoudi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NIDCR NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Platelet rich blood derivatives have been widely used in different fields of medicine and stem cell based tissue engineering. They represent natural cocktails of autologous growth factor, which could provide an alternative for recombinant protein based approaches. Platelet rich blood derivatives, such as platelet rich plasma, have consistently shown to potentiate stem cell proliferation, migration, and differentiation. Here, we review the spectrum of platelet rich blood derivatives, discuss their current applications in tissue engineering and regenerative medicine, reflect on their effect on stem cells, and highlight current translational challenges.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Department of Medicine, Biomaterials Innovation Research Center, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
- Doctoral Program in Experimental Biology and Biomedicine, Center for Neuroscience and Cell Biology, Institute for Interdisciplinary Research, University of Coimbra, 3030-789 Coimbra, Portugal.
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA.
- Department of Bioindustrial Technologies, College of Animal Bioscience and Technology, Konkuk University, Hwayang-dong, Gwangjin-gu, Seoul 143-701, Republic of Korea.
- Department of Physics, King Abdulaziz University, Jeddah 21569, Saudi Arabia.
Förderung
- NIBIB NIH HHS
- NIDCR NIH HHS
- NIAMS NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Masoudi, E., Ribas, J., Kaushik, G., Leijten, J., & Khademhosseini, A. (2016). Platelet-Rich Blood Derivatives for Stem Cell-Based Tissue Engineering and Regeneration. Current Stem Cell Reports, 2(1), 33-42. https://doi.org/10.1007/s40778-016-0034-8
Vancouver
Masoudi E, Ribas J, Kaushik G, Leijten J, Khademhosseini A. Platelet-Rich Blood Derivatives for Stem Cell-Based Tissue Engineering and Regeneration. Current Stem Cell Reports. 2016;2(1):33-42. doi:10.1007/s40778-016-0034-8
BibTeX
@article{Masoudi2016,
author = {Masoudi, Elham and Ribas, João and Kaushik, Gaurav and Leijten, Jeroen and Khademhosseini, Ali},
title = {Platelet-Rich Blood Derivatives for Stem Cell-Based Tissue Engineering and Regeneration},
journal = {Current Stem Cell Reports},
year = {2016},
volume = {2},
number = {1},
pages = {33--42},
doi = {10.1007/s40778-016-0034-8}
}
EUVIMED